These are materials from the Women’s health half day conference that took place on 12 November 2025. This presentation will be available to view until 12 November 2026.
The conference provided a deep dive into the most significant updates in HRT and contraception, equipping clinicians with practical tools to navigate evolving guidelines and patient expectations.
The session will begin with the newly published FSRH guidance (Jan 2024), focusing on changes to injectable contraception and implications for service delivery. The second half turns to menopause, covering the major changes in the 2024 NICE guideline, including the growing role of testosterone therapy, personalised treatment planning, and the demystification of societal beliefs around HRT and bioidentical hormones.
Real-world case scenarios and interactive polls will ensure take-home strategies are directly translatable to practice.
Topics covered:
- GLP-1 & FSRH 2024 updates on contraception
- injectable contraceptive choices and real-world prescribing challenges
- advice on practical HRT prescribing: what, when, and how
- advice on testosterone in menopause: prescribing safely, busting myths
- benefits and risks of blood tests and how to manage patient expectations
Please note, this presentation is only available to those who attended the course on the day.
All presentations are watermarked and are not to be shared with others. These will only be available to view online up until 12 November 2026.
